Actinium Pharmaceuticals logo

Actinium Pharmaceuticals share price today

(ATNM)

Actinium Pharmaceuticals share price is $1.22 & ₹103.94 as on 25 Dec 2024, 2.30 'hrs' IST

$1.22

-0.02

(-1.61%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Actinium Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Actinium Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Actinium Pharmaceuticals. Get details on the Indian mutual funds that are investing in Actinium Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Actinium Pharmaceuticals's financials.

Actinium Pharmaceuticals share price movements

  • Today's Low: $1.15
    Today's High: $1.24

    Day's Volatility :7.26%

  • 52 Weeks Low: $1.10
    52 Weeks High: $10.24

    52 Weeks Volatility :89.26%

Actinium Pharmaceuticals Returns

PeriodActinium Pharmaceuticals IncIndex (Russel 2000)
3 Months
-31.84%
0.0%
6 Months
-83.49%
0.0%
1 Year
-76.89%
0.0%
3 Years
-80.91%
-21.1%

Actinium Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$1.24
Open
$1.24
Today's High
$1.24
Today's Low
$1.15
Market Capitalization
$38.1M
Today's Volume
$141.8K
52 Week High
$10.24
52 Week Low
$1.1
Revenue TTM
$81.0K
EBITDA
$-46.5M
Earnings Per Share (EPS)
$-1.39
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-87.96%

How to invest in Actinium Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Actinium Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Actinium Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Actinium Pharmaceuticals or ATNM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Actinium Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Actinium Pharmaceuticals shares which would translate to 0.698 fractional shares of Actinium Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Actinium Pharmaceuticals, in just a few clicks!

Returns in Actinium Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Actinium Pharmaceuticals investment value today

Current value as on today

₹25,345

Returns

₹74,655

(-74.66%)

Returns from Actinium Pharmaceuticals Stock

₹76,894 (-76.89%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Actinium Pharmaceuticals

56%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Actinium Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 56% more investors are searching Actinium Pharmaceuticals in the last 30 days versus the previous period.

Analyst Recommendation on Actinium Pharmaceuticals

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Actinium Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Actinium Pharmaceuticals

What analysts predicted

Upside of 309.84%

Current:

$1.22

Target:

$5.00

Insights on Actinium Pharmaceuticals

  • Price Movement

    In the last 7 days, ATNM stock has moved up by 8.9%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 114.0K → 81.0K (in $), with an average decrease of 29.0% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -8.67M → -11.56M (in $), with an average decrease of 16.4% per quarter
  • ATNM vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 106.0%
  • ATNM vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 106.9%
  • Price to Sales

    ForATNM every $1 of sales, investors are willing to pay $406.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Actinium Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Actinium Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Actinium Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Actinium Pharmaceuticals Inc
-13.48%
-83.49%
-76.89%
-80.91%
-82.07%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Actinium Pharmaceuticals Inc
NA
NA
0.0
-1.42
-0.88
-0.31
NA
1.32
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Actinium Pharmaceuticals Inc
Buy
$38.1M
-82.07%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Actinium Pharmaceuticals

actinium pharmaceuticals, inc. (www.actiniumpharma.com) (nyse mkt: atnm) is a new york-based biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. actinium's targeted radiotherapy is based on its proprietary delivery platform for the therapeutic utilization of alpha-emitting actinium-225 and bismuth-213 and certain beta emitting radiopharmaceuticals in conjunction with monoclonal antibodies. the company’s lead radiopharmaceutical iomab™-b will be used in preparing patients for hematopoietic stem cell transplant, commonly referred to as bone marrow transplant. the company is preparing a single, pivotal, multicenter phase 3 clinical study of iomab™-b in refractory and relapsed acute myeloid leukemia (aml) patients over the age of 55 with a primary endpoint of durable complete remission. the company’s second program, actimab-a, is continuing its clinical development in a phase 1/2 trial for newly diagnosed aml patients o
Organization
Actinium Pharmaceuticals
Employees
49
CEO
Mr. Sandesh C. Seth M.B.A., M.S.
Industry
Health Technology

Management People of Actinium Pharmaceuticals

NameTitle
Mr. Sandesh C. Seth M.B.A., M.S.
Chairman & CEO
Mr. Steven O'Loughlin BS
CFO & Corporate Secretary
Dr. Paul Diamond Esq., Ph.D.
Vice President of Patent & Legal Counsel
Dr. Avinash Desai M.D.
Chief Medical Officer
Ms. Jenny Hsieh
Chief Strategy Officer
Ms. Sunitha Lakshminarayanan
Senior VP, Head of CMC & Product Development
Ms. Caroline Yarbrough
Chief Commercial Officer
Ms. Lynn M. Bodarky M.B.A.
Chief Business Officer
Mr. J. C. Simeon
Executive Director of Quality Assurance
Dr. Madhuri Vusirikala M.D.
Vice President of Clinical Development BMT & Cellular Therapy

Important FAQs about investing in Actinium Pharmaceuticals from India :

What is Actinium Pharmaceuticals share price today?

Actinium Pharmaceuticals share price today stands at $1.22, Open: $1.24 ; Previous Close: $1.24 ; High: $1.24 ; Low: $1.15 ; 52 Week High: $10.24 ; 52 Week Low: $1.10. The stock opens at $1.24, after a previous close of $1.24. The stock reached a daily high of $1.24 and a low of $1.15, with a 52-week high of $10.24 and a 52-week low of $1.10.

Can Indians buy Actinium Pharmaceuticals shares?

Yes, Indians can invest in the Actinium Pharmaceuticals (ATNM) from India.

With INDmoney, you can buy Actinium Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Actinium Pharmaceuticals at zero transaction cost.

How can I buy Actinium Pharmaceuticals shares from India?

It is very easy to buy Actinium Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Actinium Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Actinium Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Actinium Pharmaceuticals stocks?

To start investing in Actinium Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Actinium Pharmaceuticals

Today’s highest price of Actinium Pharmaceuticals (ATNM) is $1.24.

Today’s lowest price of Actinium Pharmaceuticals (ATNM) is $1.15.

What is today's market capitalisation of Actinium Pharmaceuticals

Today's market capitalisation of Actinium Pharmaceuticals ATNM is 38.1M

What is the 52 Week High and Low Range of Actinium Pharmaceuticals

  • 52 Week High

    $10.24

  • 52 Week Low

    $1.10

What are the historical returns of Actinium Pharmaceuticals?

  • 1 Month Returns

    -13.48%

  • 3 Months Returns

    -83.49%

  • 1 Year Returns

    -76.89%

  • 5 Years Returns

    -82.07%

Who is the Chief Executive Officer (CEO) of Actinium Pharmaceuticals

Mr. Sandesh C. Seth M.B.A., M.S. is the current Chief Executive Officer (CEO) of Actinium Pharmaceuticals.